関連する実験動画
Updated: Sep 30, 2025

08:26
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
1.8K
パンデミックが始まる前にそれを止める:SARS-CoV-2から学んだ教訓
Aled M Edwards1, Ralph S Baric2, Erica Ollmann Saphire3,4
1Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
まとめ
COVID-19のワクチンと薬は 何十年にもわたる科学的な投資によって 期待を寄せています しかし,進行中のパンデミックは,将来の世界的な健康危機を防ぐための準備を強化する必要性を強調しています.
科学分野:
- ウイルス学
- 免疫学
- 薬理学について
背景:
- COVID-19 パンデミックは2021年末までに500万人以上の死亡を引き起こしました.
- 深刻な急性呼吸器症候群の新型コロナウイルス2型 (SARS-CoV-2) は,世界的に進化し続けています.
- 現行のパンデミック対策は,SARS-CoV-2の急速な感染拡大と影響により困難となった.
研究 の 目的:
- COVID-19のワクチン,抗体療法,抗ウイルス薬の開発をレビューする.
- 基礎科学と技術への長期投資の基本的役割を強調する.
- 将来のパンデミック対策と予防のための戦略を推奨する.
主な方法:
- 承認されたワクチン,抗体療法,およびCOVID-19に対する抗ウイルス薬のレビュー.
- これらの医療対策を支える科学技術的進歩の分析
- COVID-19 パンデミック対策から得た教訓をまとめました.
主要な成果:
- 承認されたCOVID-19ワクチン,抗体療法,抗ウイルス薬は,重要な科学的成果を表しています.
- これらの医療の進歩は 何十年にもわたる研究と技術開発によって可能になりました
- SARS-CoV-2は,世界的なパンデミック対策の重要なテストを提示した.
結論:
- COVID-19対策の成功は,科学への持続的な投資の価値を示しています.
- 将来のパンデミックに対する備えを改善するために,緊急の措置が必要である.
- 積極的な対策は 影響を最小限に抑え 将来の世界的な健康緊急事態を 防ぐことができます
関連する概念動画
Steps in Outbreak Investigation
241
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
241
Infection
8.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.9K
Principles of Disease Surveillance
203
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
203
Healthcare Associated Infections II: Preventive Measures
3.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.0K
Single Nucleotide Polymorphisms-SNPs
16.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.2K
Vaccinations
45.5K
Overview
45.5K

